Portable Dna Testing Service Pitch Deck Template, Editable in PowerPoint

Why Now and What Urgent Problem?

The market urgently needs faster, decentralized genetic analysis because traditional lab processes cause delays that impact critical, time-sensitive decisions in healthcare and agriculture. Our mobile genomics solutions solve the logistics bottleneck by bringing the lab to the client, delivering results in hours, not days.

Decentralized Diagnostics Demand

• Demand for point-of-care diagnostics is surging.
• Traditional labs slow down critical decisions.
• Regulatory clarity enables field DNA sequencing.

What Do You Do and Why Will You Win?

We provide on-site genetic analysis using a mobile fleet of certified practitioners and portable DNA devices, backed by proprietary bioinformatics data interpretation software. We win by focusing on high-margin, recurring contracts in specialized verticals and maintaining a strong unit economic profile.

Unit Economics & Financial Strength

The business model shows strong contribution margins because variable costs (DNA Reagents & Consumables at 10.0% of revenue in 2026, plus Device Calibration at 3.0%) are low relative to the high average treatment price (e.g., $400 for Research Support). However, significant fixed costs, including $1.3 million in 2026 wages and $122,400 in fixed OpEx, require aggressive scaling to reach the EBITDA positive mark of $435,000 by Year 3 (2028).

• High contribution margin (80% before fixed costs).
• Scalable workforce of Mobile Practitioners ($70,000 salary).
• Proprietary CLIA compliance mobile

Who Buys and How Big is the Opportunity?

The opportunity is large and segmented, targeting high-value B2B clients across Healthcare Clinics, Corporate Wellness Programs, and Agricultural Technology Companies. By scaling our practitioner base from 12 in 2026 to 123 by 2030, we capture market share in multiple, distinct verticals simultaneously.

Scaling Capacity and Market Reach

Our growth strategy relies on increasing the number of mobile practitioners and improving utilization rates. For example, the Healthcare Screeners segment grows from 5 practitioners in 2026 (60.0% utilization) to 50 practitioners in 2030 (85.0% utilization), while the price per treatment increases from $150 to $170. This aggressive staffing plan drives the projected five-year EBITDA to $6,953,000, validating the scalability of the ~portable DNA testing service model.

• Targeting high-value B2B contracts first.
• Aggressive practitioner growth (12x in five years).
• Focus on high-price segmen

This pitch deck template is defintely designed based on investor best practices, covering the core 8 to 12 slides VCs expect. This structure enhances your credibility immediately, saves you time, and ensures your ~portable DNA testing service pitch aligns with what professional investors need to see in a winning presentation.

Follows proven investor expectations

Covers Problem, Solution, Market, Team

Speeds up preparation time significantly

The pitch deck is fully editable in Microsoft PowerPoint or Google Slides, giving you complete control over your presentation. This flexibility allows you to adapt the content, design, and branding to your unique mobile genomics solutions business model without needing expensive design or technical skills.

Customize text, colors, and fonts

Works across all major platforms

Adaptable to your unique branding

The template helps you craft a compelling narrative by focusing on the core problem-solution framework. This structure clarifies the startup’s value proposition—the rapid DNA testing business—and engages investors from the very first slides, making your complex offering simple to understand.

Clarifies value proposition fast

Engages investors immediately

Focuses on market pain points

The template includes structured slides for demonstrating market demand, which is crucial for any field DNA sequencing venture. Showcasing industry trends, Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) builds credibility and investor confidence in your scale potential.

Quantifies the market opportunity

Validates potential for rapid growth

Includes TAM/SAM/SOM formats

This pitch deck makes it easy to communicate how your mobile genomics solutions business generates revenue across different segments. Clear financial logic and multiple monetization paths—like Fee-For-Service and Package Fees—reassure investors of the company’s scalability and long-term viability.

Shows clear revenue streams

Maps pricing and unit economics

Proves scalability and viability

The template includes a dedicated slide to compare competitors in the point-of-care diagnostics space. This helps you position your startup’s advantages clearly, proving why your on-site genetic analysis offering is more compelling and defensible than existing lab services or equipment suppliers.

Highlights key differentiators

Compares rivals effectively

Shows defensible positioning

The template simplifies how startups present their fundraising needs and use of capital. Pre-built structures clarify capital usage, align with investor expectations, and communicate the potential Return on Investment (ROI) from the capital deployed into your genetic sample logistics and operations.

Clarifies capital usage plan

Aligns with investor expectations

Shows disciplined capital deployment

Using this template saves founders hours of work and thousands in consulting or design fees. It delivers an instantly professional, ready-to-use presentation without sacrificing quality, allowing you to focus on running your rapid DNA testing business instead of designing slides.

Saves hours of design work

Reduces reliance on expensive consultants

Delivers instant professional quality

The pitch deck is built to suit startups at any growth phase, whether you are pre-seed or seeking Series A funding. Its flexible structure supports various fundraising efforts, adapting easily to each stage’s specific messaging needs, from proving concept to demonstrating scaling traction.

Supports pre-seed through Series A

Modular and easily reusable

Adapts to specific stage messaging